These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 21476917

  • 1. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C.
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [Abstract] [Full Text] [Related]

  • 2. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH.
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [Abstract] [Full Text] [Related]

  • 3. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E.
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [Abstract] [Full Text] [Related]

  • 4. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic steatohepatitis.
    Brunt EM.
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

  • 7. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 8. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [Abstract] [Full Text] [Related]

  • 9. Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
    Machado MV, Cortez-Pinto H.
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):213-22. PubMed ID: 21476916
    [Abstract] [Full Text] [Related]

  • 10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Fukusato T.
    World J Gastroenterol; 2014 Nov 14; 20(42):15539-48. PubMed ID: 25400438
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec 14; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 12. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar 14; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 13. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA, Kunde SS, Lazenby AJ, Clements RH.
    Hepatology; 2004 Aug 14; 40(2):475-83. PubMed ID: 15368453
    [Abstract] [Full Text] [Related]

  • 14. Natural history of nonalcoholic steatohepatitis.
    Liou I, Kowdley KV.
    J Clin Gastroenterol; 2006 Mar 14; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [Abstract] [Full Text] [Related]

  • 15. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun 14; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 16. [Steatosis and steatohepatitis in diabetic patient].
    Hůlek P, Dresslerová I.
    Vnitr Lek; 2011 Apr 14; 57(4):364-7. PubMed ID: 21612059
    [Abstract] [Full Text] [Related]

  • 17. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT, de Oliveira CP, Corrêa-Giannella ML, Soares IC, Kubrusly MS, Bellodi-Privato M, de Mello ES, de Lima VM, Carrilho FJ, Alves VA.
    Liver Int; 2011 Mar 14; 31(3):377-85. PubMed ID: 21108736
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J, Choi SS, Diehl AM.
    Semin Liver Dis; 2008 Nov 14; 28(4):370-9. PubMed ID: 18956293
    [Abstract] [Full Text] [Related]

  • 19. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA, Feldstein AE.
    J Dig Dis; 2011 Feb 14; 12(1):10-6. PubMed ID: 21091933
    [Abstract] [Full Text] [Related]

  • 20. Pathology of nonalcoholic fatty liver disease.
    Yeh MM, Brunt EM.
    Am J Clin Pathol; 2007 Nov 14; 128(5):837-47. PubMed ID: 17951208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.